Supporting Adults with Chronic Kidney Disease to engage in shared decision making successfully (SUCCESS): A Pragmatic randomised controlled trial of the SUCCESS intervention.

Not Applicable

Recruiting

• Conditions: Chronic Kidney Disease; Renal and Urogenital - Kidney disease

• Registration Number: ACTRN12621000235808
• Lead Sponsor: niversity of Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2021-03-05
• Last Update Posted: 24 May 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 384

Inclusion Criteria

1. Stage 5 chronic kidney disease
2. Currently receiving haemodialysis at an in-patient or outpatient renal dialysis centre, home-based haemodialysis or peritoneal dialysis
3. Ability to read and speak English sufficiently well to respond to written questions without assistance
4 Ability to provide written informed consent.

Exclusion Criteria

1. Unable to provide informed consent
2. Under 18 years

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Shared decision making assessed using the Decision Self Efficacy Scale<br><br><br> <br>[At 0, 3, 6 (primary endpoint) and 12 months of app usage];Health Literacy assessed using Health Literacy Questionnaire 0, 3, 6 (primary endpoint) and 12 months. [At 0, 3, 6 (primary endpoint) and 12 months of app usage];Rate of unscheduled health encounters reported by participants at follow up visits.. [At 3, 6 (primary endpoint) and 12 months of app usage.]

Secondary Outcome Measures

Name	Time	Method
Quality of Life assessed using the EQ5D-5L (Primary Outcome)[At 3, 6 (Primary endpoint) and 12 months of app usage.];Changes in symptom burden assessed using the Palliative care Outcome Scale (Renal) (Primary Outcome)[At 3, 6 (Primary Endpoint) and 12 months of app usage.];Knowledge assessed using a a Knowledge questionnaire purpose-designed[At 3, 6 and 12 months of app usage.];Confidence assessed using a purpose-designed questionnaire[At 3, 6, and 12 months of app usage.];Averaged interdialytic weight change assessed using digital scales[At 3, 6, and 12 months of app usage.];Behaviour and behavioural intentions assessed by theory-informed behaviour and intentions questions. [At 3, 6 and 12 months of app usage. ];Health service utilisation assessed by self-report at follow up visits.[At 3, 6 and 12 months of app usage.]